Díez J, Panizo A, Hernández M, Pardo J
Department of Vascular Pathophysiology, School of Medicine, University of Navarra, Pamplona, Spain.
Hypertension. 1997 Mar;29(3):776-80. doi: 10.1161/01.hyp.29.3.776.
Whereas the protein product of the Bcl-2 gene inhibits apoptosis, the protein product of the Bax gene acts as a promoter of apoptosis. To gain insight into the regulation of apoptosis in vascular smooth muscle cells in arterial hypertension, we investigated the expression of the proteins Bcl-2 and Bax in small intramyocardial arteries of 36-week-old normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). In addition, 16-week-old SHR were treated for 20 weeks with the angiotensin-converting enzyme inhibitor quinapril and killed at 36 weeks of age. We measured the percentages of smooth muscle cells expressing these proteins using monoclonal antibodies and the avidin-biotin immunoperoxidase method. Compared with WKY, untreated SHR exhibited increased (P<.001) Bcl-2 expression and similar Bax expression. Values of Bcl-2 measured in quinapril-treated SHR were significantly lower than values measured in untreated SHR and similar to values measured in WKY. Quinapril-treated SHR showed higher (P<.001) Bax expression than WKY and untreated SHR. Bcl-2 expression was directly correlated with systolic pressure. Inverse correlations were found between the expression of Bax and the activities of both cardiac and circulating angiotensin-converting enzyme. These findings suggest that smooth muscle cell apoptosis might be inhibited in small arteries of adult SHR as a consequence of an excess of the protein Bcl-2. In addition, our results suggest that chronic angiotensin-converting enzyme inhibition might restore the susceptibility to apoptosis in these cells through stimulation of the protein Bax.
Bcl-2基因的蛋白质产物可抑制细胞凋亡,而Bax基因的蛋白质产物则作为细胞凋亡的促进剂。为深入了解动脉高血压中血管平滑肌细胞凋亡的调控机制,我们研究了36周龄正常血压的Wistar-Kyoto大鼠(WKY)和自发性高血压大鼠(SHR)心肌内小动脉中Bcl-2和Bax蛋白的表达情况。此外,并对16周龄的SHR用血管紧张素转换酶抑制剂喹那普利治疗20周,然后在36周龄时处死。我们使用单克隆抗体和抗生物素蛋白-生物素免疫过氧化物酶法测量了表达这些蛋白质的平滑肌细胞的百分比。与WKY相比,未经治疗的SHR的Bcl-2表达增加(P<0.001),而Bax表达相似。喹那普利治疗的SHR中测得的Bcl-2值显著低于未经治疗的SHR中测得的值,且与WKY中测得的值相似。喹那普利治疗的SHR的Bax表达高于WKY和未经治疗的SHR(P<0.001)。Bcl-2表达与收缩压直接相关。发现Bax的表达与心脏和循环血管紧张素转换酶的活性呈负相关。这些发现表明,由于蛋白质Bcl-2过量,成年SHR小动脉中的平滑肌细胞凋亡可能受到抑制。此外,我们的结果表明,慢性血管紧张素转换酶抑制可能通过刺激蛋白质Bax来恢复这些细胞对凋亡的敏感性。